-
The Effects of Microwave Thermotherapy for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Prospective, Randomized Study
-
Hong Chung, Hoon Choi, Tag Keun Yoo, Jeong Man Cho, Hong Sup Kim
-
Urogenit Tract Infect 2017;12(1):35-41. Published online April 30, 2017
-
-
-
 Abstract
 PDF
- Purpose: Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) causes pain and urinary symptoms that involve the prostate and/or other parts of the male. We analyzed the clinical outcomes of medication and microwave thermotherapy.
Materials and Methods: A total of 132 patients with CP/CPPS for at least 3 months were assigned to one of the three study groups (group A: medication; group B: thermotherapy; group C: combination therapy). The NIH-CPSI was recorded at baseline, and at weeks 2, 4, 8, and 12 post-therapy. EPS was evaluated, and semen analysis was performed to assess the changes in prostatic inflammation. Moreover, patient satisfaction questionnaire was completed.
Results: Comparisons between groups A and B, as well as between groups B and C showed no significant changes in pain, quality of life, and total scores. At week 12, group C, when compared with group A, had a significantly improved voiding score (4.19±3.02 vs. 2.71±2.30, p=0.019) and EPS (12.47±15.91 vs. 3.73±4.82, p=0.003). At week 4, the patient satisfaction score in group C was significantly different from that in other groups (p=0.043), but there was no difference at week 12 (p＞0.05). There was no statistically significant difference in laboratory test results, PSA, and prostate volume between the three groups at baseline and week 12. Complications of thermotherapy resolved with conservative management.
Conclusions: Our results showed that a combination of medication and thermotherapy improved NIH-CPSI and patient satisfaction in CP/CPPS more than medication alone. We suggested that thermotherapy could be another treatment option for CP/CPPS.
-
Can Betadine Gauze Compression Be Decreased Significant Complications after Prostate Needle Biopsy under Transrectal Ultrasound at Outpatient Department?: Single Clinician’s Experience
-
Hong Chung, Hong Sup Kim, Sang-Kuk Yang
-
Korean J Urogenit Tract Infect Inflamm 2012;7(1):43-49. Published online April 30, 2012
-
-
-
Abstract
PDF
- "Purpose: Recently, the number of patients undergoing prostate biopsy has increased due to the development of cancer screening test with prostate specific antigen. Prostate needle biopsy under transrectal ultrasound (Bx-TRUS) is the standard procedure to diagnose prostate cancer. We evaluated the incidence of significant infectious and bleeding complications performed by a single urologist with unique methods of betadine gauze compression after Bx-TRUS. Materials and Methods: We retrospectively evaluated the medical records of 299 patients, who underwent Bx-TRUS, from March 2007 to December 2011. All patients received oral levofloxacin 500mg for 4 days. Significant complications, related to infection with fever and persistent rectal bleeding, were evaluated within 4 weeks after biopsy. Patients who presented infectious complications were treated with intravenous ceftriaxone 2.0gm for 5 or 7 days. Patients who present significant anal bleeding were managed with primary closure by colorectal clinic in the department of surgery. Results: Among 299 patients, 4patients (1.3%) developed post-biopsy infections and hemorrhage. Those major complications were catergorized as acute prostatitis (2 patients, 0.7%) and rectal bleeding (2 patients, 0.7%). Of the 2 cases with post-biopsy infection, 1 case (Escherichia coli) had positive urine and blood culture. E. coli was sensitive to cephalosporine, but was resistant to fluoroquinolone. Conclusions: The results of this study suggest that betadine compression after Bx-TRUS may play the role of decreasing or preventing the significant complications, such as febrile infections and persistent rectal bleeding. Further, well designed study is needed to evaluate the clinical implication of betadine gauze compression after Bx-TRUS."
-
Percutaneous Management of Renal Abscess in Polycystic Kidney Disease
-
Hong Chung, Yong Ik Lee, Hong Sup Kim, Sang-Kuk Yang
-
Korean J Urogenit Tract Infect Inflamm 2011;6(2):209-212. Published online October 31, 2011
-
-
-
Abstract
PDF
- Autosomaldominant polycystic kidney disease (ADPKD) is one of the commonest hereditary disorders and the most common life-threatening genetic disease, affecting an estimated 12.5 million people worldwide. PKD are congenital and bilateral diseases, and those symptoms almost never appear until after age 40. Urinary tract infection occurs with increased frequency in ADPKD and infection in ADPKD is a particularly serious complication. Here, we report a 79-year-old man with an intermittent high fever during 2 months and bulging mass at the right flank.
|
KAUTI
